Compare Aevo (AEVO) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aevo vs Mira — how do they compare? Aevo trades at Rp346.93 (market cap Rp322,33M, Rp54,7M 24h volume), while Mira trades at Rp700.16 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: Aevo is the larger of the two by market cap, and Aevo's circulating supply is 932,7M / 1B AEVO (94%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 89 Days and Mira for 22 Days on average.
| AEVO | MIRA | |
|---|---|---|
Market Cap | Rp322,33M | Rp224,01M |
Volume (24h) | Rp54,7M | Rp102,95M |
Circulating Supply | 932,7M / 1B AEVO (94%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 89 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aevo is currently trading at Rp345.33 with a market cap of Rp321.95 million, exhibiting a bearish technical signal driven by moving averages. The token is near its pivot point of Rp348, with key support at Rp339 and resistance at Rp352. No recent protocol updates or major ecosystem developments were noted. The circulating supply is 932.6 million AEVO out of a max supply of 1 billion, with 94% in circulation.
Overall outlook is cautious due to bearish technicals and lack of fundamental catalysts. Key opportunities include potential rebounds from support levels, while major risks involve low liquidity, high volatility, and absence of recent positive developments. Investors should monitor for any ecosystem updates or shifts in market sentiment.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Aevo
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
